Key result
Molecular autopsy identifies pathogenic variants in sudden unexplained death to guide preventive care for surviving relatives.
Why the study?
Hereditary aortopathies cause sudden cardiac death in young individuals, and post-mortem genetic testing can assess genetic risk to guide preventive strategies for affected relatives.
Does post-mortem genetic testing and family screening prevent sudden cardiac death in relatives of young victims with hereditary aortopathies?
Does post-mortem genetic testing and family screening prevent sudden cardiac death in relatives of young victims with hereditary aortopathies?
Molecular autopsy in cases of sudden unexplained death is essential for diagnosing hereditary aortopathies and initiating life-saving preventive monitoring in affected family members.
Answers are grounded in this paper and cite their sources.
May support molecular autopsy in unexplained sudden death; leaves open prospective validation of family screening benefits.
Hereditary aortopathies are a group of rare genetic diseases affecting the aorta and its major branches, and they represent a cause of sudden cardiac death. These pathologies are classified into syndromic hereditary aortopathies and non-syndromic hereditary aortopathies. The epidemiology of hereditary aortopathies varies according to the specific genetic condition involved; however, these disorders are believed to account for a significant proportion of sudden cardiac death in young individuals with a family history of inherited cardiovascular conditions. The causes of hereditary aortopathies are primarily genetic, with pathogenic variants in various genes encoding structural proteins of the vascular wall, leading to dissection, aneurysms, rupture, and ultimately sudden cardiac death. When the cause of death remains unknown after an autopsy, it is referred to as sudden unexplained death, and post-mortem genetic testing, known as a molecular autopsy, is crucial to confirm hereditary aortopathies and assess the genetic risk in the patient's relatives. This helps to facilitate diagnostic and therapeutic pathways and/or implement monitoring strategies to prevent sudden cardiac death. In this state-of-the-art review, we focus on syndromic and non-syndromic hereditary aortopathies causing sudden cardiac death in the young and explore preventive strategies for affected family members.
No takes yet. Share an insight, caveat, or question.
Salzillo et al. (2024) conducted a review in Hereditary aortopathies and sudden cardiac death in the young. Molecular autopsy and genetic testing was evaluated. Post-mortem genetic testing (molecular autopsy) is crucial for identifying pathogenic variants in victims of sudden unexplained death, enabling targeted preventive strategies for affected relatives.
Synapse has enriched 10 related papers. Consider them for comparative context: